Edward J. Ludwig has been a director of Boston Scientific since March 2014. Mr. Ludwig is the former Chairman of the board of Becton, Dickinson and Company (“BDX”), a global medical technology company, having served in that position from February 2002 through June 2012. He also served as BDX’s Chief Executive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Mr. Ludwig joined BDX as a senior financial analyst in 1979. Prior to joining BDX, Mr. Ludwig served as a senior auditor with Coopers and Lybrand (now PricewaterhouseCoopers) where he earned his CPA, and as a financial and strategic analyst at Kidde, Inc. Mr. Ludwig serves as lead director on Aetna Inc.’s board of directors and chairs its finance committee and is a member of the board of directors of Xylem, Inc. Additionally, Mr. Ludwig served as vice chair of the board of trustees of the Hackensack University Medical Center Network from 2012 to 2015. Mr. Ludwig received a B.A. degree in economics and accounting from The College of the Holy Cross and a M.B.A. degree from Columbia University.

Edward J. Ludwig has broad interests in health care business